J F Guest
Affiliation: CATALYST Health Economics Consultants
Guest J, Naik N, Sladkevicius E, Coombs J, Gray E. Utility values for chronic myelogenous leukemia chronic phase health states from the general public in the United Kingdom. Leuk Lymphoma. 2012;53:928-33 pubmed publisher
..001). This study demonstrated and quantified the impact that more robust treatment responses have on the health-related quality of life of patients with chronic phase CML. ..
Guest J, Clegg J, Davie A, McCloskey E. Costs and consequences of using pamidronate compared with zoledronic acid in the management of breast cancer patients in the UK. Curr Med Res Opin. 2005;21:805-15 pubmed
Guest J, Davie A, Clegg J. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK. Curr Med Res Opin. 2005;21:817-26 pubmed
..Moreover, the acquisition cost of a drug should not be used as an indication of the cost effectiveness of a given method of care. ..
Guest J, Candy D, Clegg J, Edwards D, Helter M, Dale A, et al
. Clinical and economic impact of using macrogol 3350 plus electrolytes in an outpatient setting compared to enemas and suppositories and manual evacuation to treat paediatric faecal impaction based on actual clinical practice in England and Wales. Curr Med Res Opin. 2007;23:2213-25 pubmed
Guest J, Clegg J, Helter M. Cost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation in the UK. Curr Med Res Opin. 2008;24:1841-52 pubmed
Guest J, Jenssen T, Houge G, Aaseboe W, Tøndel C, Svarstad E. Modelling the resource implications of managing adults with Fabry disease in Norway favours home infusion. Eur J Clin Invest. 2010;40:1104-12 pubmed publisher
Guest J, Panca M, Baeyens J, de Man F, Ljungqvist O, Pichard C, et al
. Health economic impact of managing patients following a community-based diagnosis of malnutrition in the UK. Clin Nutr. 2011;30:422-9 pubmed publisher
..After adjusting for age and comorbidity, malnutrition remained an independent predictor of mortality. ..
Weidlich D, Andersson F, Oelke M, Drake M, Jonasson A, Guest J. Annual direct and indirect costs attributable to nocturia in Germany, Sweden, and the UK. Eur J Health Econ. 2017;18:761-771 pubmed publisher
..Clinical and economic benefits could accrue from an increased awareness of the impact that nocturia imposes on patients, health services, and society as a whole. ..
Guest J, Valovirta E. Modelling the resource implications and budget impact of new reimbursement guidelines for the management of cow milk allergy in Finland. Curr Med Res Opin. 2008;24:1167-77 pubmed